Evaluación económica de la vacunación frente al neumococo en mayores de 65 años de Castilla y León

López-Gobernado, Miguel; Pérez-Rubio, Alberto; López-García, Eva; Mayo Iscar, Agustín; Cabezas Pascual, Carlos; Eiros, Jose María.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 54(6): 309-314, nov.-dic. 2019. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-192723

Documentos relacionados

  1. [Economic evaluation of pneumococcal vaccination in adults aged over 65 years in Castilla y León (SPAIN)].
  2. Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia.
  3. Effectiveness of Pneumococcal Vaccination Against Pneumococcal Pneumonia Hospitalization in Older Adults: A Prospective, Test-Negative Study.
  4. Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions.
  5. Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015.
  6. Economic burden and epidemiology of pneumonia in Korean adults aged over 50 years.
  7. Prior pneumococcal vaccination improves in-hospital mortality among elderly population hospitalized due to community-acquired pneumonia.
  8. Epidemiology of community-acquired pneumonia caused by S treptococcus pneumoniae in older adults: a narrative review.
  9. Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia.
  10. The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018.